| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.29 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |